vs
Side-by-side financial comparison of Life360, Inc. (LIF) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($250.2M vs $146.0M, roughly 1.7× Life360, Inc.). Life360, Inc. runs the higher net margin — 88.8% vs 3.0%, a 85.8% gap on every dollar of revenue. On growth, Life360, Inc. posted the faster year-over-year revenue change (26.4% vs -3.0%). Over the past eight quarters, Life360, Inc.'s revenue compounded faster (36.6% CAGR vs 11.8%).
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
LIF vs USNA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $146.0M | $250.2M |
| Net Profit | $129.7M | $7.5M |
| Gross Margin | 75.1% | 76.2% |
| Operating Margin | 6.1% | 5.5% |
| Net Margin | 88.8% | 3.0% |
| Revenue YoY | 26.4% | -3.0% |
| Net Profit YoY | 1425.9% | -20.0% |
| EPS (diluted) | $1.53 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $250.2M | ||
| Q4 25 | $146.0M | $226.2M | ||
| Q3 25 | $124.5M | $213.7M | ||
| Q2 25 | $115.4M | $235.8M | ||
| Q1 25 | $103.6M | $249.5M | ||
| Q4 24 | $115.5M | $213.6M | ||
| Q3 24 | $92.9M | $200.2M | ||
| Q2 24 | $84.9M | — |
| Q1 26 | — | $7.5M | ||
| Q4 25 | $129.7M | $180.0K | ||
| Q3 25 | $9.8M | $-6.5M | ||
| Q2 25 | $7.0M | $9.7M | ||
| Q1 25 | $4.4M | $9.4M | ||
| Q4 24 | $8.5M | $4.5M | ||
| Q3 24 | $7.7M | $10.6M | ||
| Q2 24 | $-11.0M | — |
| Q1 26 | — | 76.2% | ||
| Q4 25 | 75.1% | 78.2% | ||
| Q3 25 | 78.0% | 77.2% | ||
| Q2 25 | 78.4% | 78.7% | ||
| Q1 25 | 80.6% | 79.0% | ||
| Q4 24 | 74.0% | 82.0% | ||
| Q3 24 | 75.4% | 80.4% | ||
| Q2 24 | 75.0% | — |
| Q1 26 | — | 5.5% | ||
| Q4 25 | 6.1% | 1.7% | ||
| Q3 25 | 4.6% | 0.6% | ||
| Q2 25 | 1.7% | 7.1% | ||
| Q1 25 | 2.1% | 6.3% | ||
| Q4 24 | 4.9% | 3.8% | ||
| Q3 24 | -5.3% | 7.8% | ||
| Q2 24 | -2.8% | — |
| Q1 26 | — | 3.0% | ||
| Q4 25 | 88.8% | 0.1% | ||
| Q3 25 | 7.9% | -3.1% | ||
| Q2 25 | 6.1% | 4.1% | ||
| Q1 25 | 4.2% | 3.8% | ||
| Q4 24 | 7.4% | 2.1% | ||
| Q3 24 | 8.3% | 5.3% | ||
| Q2 24 | -12.9% | — |
| Q1 26 | — | $0.41 | ||
| Q4 25 | $1.53 | $-0.10 | ||
| Q3 25 | $0.11 | $-0.36 | ||
| Q2 25 | $0.08 | $0.52 | ||
| Q1 25 | $0.05 | $0.49 | ||
| Q4 24 | $0.14 | $0.23 | ||
| Q3 24 | $0.09 | $0.56 | ||
| Q2 24 | $-0.15 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $494.3M | $162.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $548.2M | — |
| Total Assets | $959.7M | $739.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $162.8M | ||
| Q4 25 | $494.3M | $158.4M | ||
| Q3 25 | $455.7M | $145.3M | ||
| Q2 25 | $432.7M | $151.3M | ||
| Q1 25 | $168.9M | $179.6M | ||
| Q4 24 | $159.2M | $181.8M | ||
| Q3 24 | $159.0M | $364.9M | ||
| Q2 24 | $160.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | $548.2M | — | ||
| Q3 25 | $391.4M | $528.1M | ||
| Q2 25 | $366.7M | $531.1M | ||
| Q1 25 | $376.3M | $529.8M | ||
| Q4 24 | $358.5M | $532.1M | ||
| Q3 24 | $339.7M | $533.1M | ||
| Q2 24 | $326.7M | — |
| Q1 26 | — | $739.0M | ||
| Q4 25 | $959.7M | $742.9M | ||
| Q3 25 | $787.5M | $726.6M | ||
| Q2 25 | $753.6M | $734.5M | ||
| Q1 25 | $455.4M | $746.6M | ||
| Q4 24 | $441.6M | $748.2M | ||
| Q3 24 | $427.4M | $671.3M | ||
| Q2 24 | $405.9M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $36.8M | — |
| Free Cash FlowOCF − Capex | $36.6M | — |
| FCF MarginFCF / Revenue | 25.1% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 0.28× | — |
| TTM Free Cash FlowTrailing 4 quarters | $86.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $36.8M | — | ||
| Q3 25 | $26.4M | $-2.0M | ||
| Q2 25 | $13.3M | $12.2M | ||
| Q1 25 | $12.1M | $15.5M | ||
| Q4 24 | $12.3M | $5.8M | ||
| Q3 24 | $6.3M | $29.5M | ||
| Q2 24 | $3.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | $36.6M | — | ||
| Q3 25 | $25.6M | $-5.2M | ||
| Q2 25 | $12.7M | $7.2M | ||
| Q1 25 | $11.9M | $12.7M | ||
| Q4 24 | $11.2M | $4.0M | ||
| Q3 24 | $6.3M | $27.1M | ||
| Q2 24 | $3.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | 25.1% | — | ||
| Q3 25 | 20.6% | -2.4% | ||
| Q2 25 | 11.0% | 3.0% | ||
| Q1 25 | 11.5% | 5.1% | ||
| Q4 24 | 9.7% | 1.9% | ||
| Q3 24 | 6.8% | 13.6% | ||
| Q2 24 | 3.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.6% | 1.5% | ||
| Q2 25 | 0.6% | 2.1% | ||
| Q1 25 | 0.1% | 1.1% | ||
| Q4 24 | 1.0% | 0.8% | ||
| Q3 24 | 0.0% | 1.2% | ||
| Q2 24 | 0.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.28× | — | ||
| Q3 25 | 2.70× | — | ||
| Q2 25 | 1.90× | 1.27× | ||
| Q1 25 | 2.75× | 1.65× | ||
| Q4 24 | 1.45× | 1.29× | ||
| Q3 24 | 0.83× | 2.78× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
